缺陷的光滑肌肉阿达1加剧血管改造和肺高血压
Yunhye Kim1, Giovanni Maroli2, Chen-Shan Chen Woodcock3,4
1Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical School, MA (Y.K., H.K., T.K., Y. Li, Y.H., B.A.R., K.Y.).
Circulation research
|October 22, 2025
概括
在肺动脉高血压 (PAH) 中,ADAR1减少RNA编辑促进炎症和血管重塑. 针对PKR提供了一种潜在的PAH治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在RNA生物学,RNA生物学.
- 心血管研究研究心血管研究
背景情况:
- 异常性肺动脉高血压 (IPAH) 是一种严重的疾病,其特点是血管重塑和右心力衰竭.
- 作用于RNA 1 (ADAR1) 的腺氨酸脱氨酶对于通过编辑双链RNA (dsRNA) 来预防自身炎症反应至关重要.
研究的目的:
- 研究ADAR1-依赖RNA编辑在IPAH患者肺动脉光滑肌细胞 (PASMCs) 内IFNβ激活中的作用.
- 阐明ADAR1缺乏导致肺高血压 (PH) 进展的机制.
主要方法:
- 从IPAH患者和健康对照中PASMC中RNA编辑水平的分析.
- 生成一种有条件的转基因小鼠模型 (Adar1SMC-KO),在光滑肌细胞中选择性地敲除Adar1,然后进行缺氧暴露以诱导PH.
- 在小鼠中评估血管改造,右心室压力和缩.
主要成果:
- IPAH-PASMCs显示ADAR1表达减少和dsRNA积累增加.
- 在ADAR1突击中,MDA5,PKR,IFNβ和IFN刺激基因被上调.
- 缺氧的Adar1SMC-KO小鼠表现出严重的PH,血管重塑和右心室压力增加.
- 在Adar1SMC-KO小鼠中的IFNβ信号促进了巨细胞的招募和肺动脉肌肉化.
- 在小鼠模型中,PKR抑制减弱了PH.
结论:
- 在光滑肌细胞中对ADAR1依赖的RNA编辑对于防止dSRNA介导的先天免疫激活和随后的PH进展至关重要.
- 这些发现强调了RNA编辑,先天免疫力和PAH中的血管重塑之间的联系.
- 向PKR代表了肺动脉高血压的有希望的治疗策略.
相关概念视频
01:30Pulmonary Hypertension: Classification and Pathogenesis
567
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
567
01:30Atherosclerosis I: Introduction
904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904
01:23Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
01:29Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
01:25Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392